Dr. Im is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2009 - 2012
- Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
- WA State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2024
- TX State Medical License 2012 - 2024
- AZ State Medical License 2023 - 2024
- LA State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- ABIMHematology
- ABIMInternal Medicine
- ABIMOncology
- Join now to see all
Publications & Presentations
PubMed
- Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center pha...Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, Denái R Milton, Alison M Gulbis, Koji Sasaki, Nitin Jain, Nicholas J Short, Tapan Kadia, May Daher, Hind Rafei, Jin S...> ;American Journal of Hematology. 2024 May 1
- 1 citationsMyeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.Uday R Popat, Oren Pasvolsky, Roland Bassett Jr, Rohtesh S Mehta, Amanda Olson, Julianne Chen, Amin M Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M Gulbis, Chitra ...> ;Blood Advances. 2023 Oct 24
- Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, Zijun Y Xu-Monette, Elias Jabbour, May Daher, Jin S Im, Qaiser Bashir, Swaminathan P Iyer, David Marin, Amanda L Olson,...> ;Bone Marrow Transplantation. 2023 Sep 1
- Join now to see all
Abstracts/Posters
- Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...Jin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II StudyJin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...Jin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: